21.77
前日終値:
$20.74
開ける:
$21.05
24時間の取引高:
103.12K
Relative Volume:
0.35
時価総額:
$703.02M
収益:
$4.12M
当期純損益:
$-56.68M
株価収益率:
-3.9275
EPS:
-5.5429
ネットキャッシュフロー:
$-51.44M
1週間 パフォーマンス:
+10.13%
1か月 パフォーマンス:
+27.03%
6か月 パフォーマンス:
-1.93%
1年 パフォーマンス:
-21.91%
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
DNTH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
DNTH
Dianthus Therapeutics Inc
|
21.86 | 612.33M | 4.12M | -56.68M | -51.44M | -5.5429 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.52 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.36 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
326.85 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
573.10 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.27 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-02 | 開始されました | William Blair | Outperform |
2024-12-20 | 開始されました | TD Cowen | Buy |
2024-10-03 | 開始されました | Oppenheimer | Outperform |
2024-07-26 | 開始されました | Robert W. Baird | Outperform |
2024-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
2024-05-16 | 開始されました | H.C. Wainwright | Buy |
2024-02-15 | 開始されました | Stifel | Buy |
2023-12-26 | 開始されました | Jefferies | Buy |
2023-11-22 | 開始されました | Wedbush | Outperform |
2023-10-30 | 開始されました | Guggenheim | Buy |
2023-09-28 | 開始されました | Raymond James | Outperform |
2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
2022-01-06 | アップグレード | Goldman | Neutral → Buy |
2021-08-20 | 再開されました | Goldman | Neutral |
2021-08-03 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-07-22 | 繰り返されました | B. Riley Securities | Buy |
2021-06-29 | 開始されました | Cantor Fitzgerald | Overweight |
2021-06-15 | 開始されました | BTIG Research | Buy |
2021-05-18 | 開始されました | B. Riley Securities | Buy |
2021-01-07 | 開始されました | Mizuho | Buy |
2020-06-08 | アップグレード | Goldman | Neutral → Buy |
2019-03-25 | ダウングレード | Goldman | Buy → Neutral |
2019-03-15 | 開始されました | Raymond James | Outperform |
すべてを表示
Dianthus Therapeutics Inc (DNTH) 最新ニュース
What drives Dianthus Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com
Dianthus Therapeutics Inc. Stock Analysis and ForecastSuperior portfolio returns - jammulinksnews.com
What analysts say about Dianthus Therapeutics Inc. stockGame-changing returns - jammulinksnews.com
Is Dianthus Therapeutics Inc. a good long term investmentRapid wealth creation - jammulinksnews.com
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 5.9%Should You Buy? - MarketBeat
Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $53.00 - MarketBeat
why dianthus therapeutics inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
what makes dianthus therapeutics inc. stock price move sharplyVolume Spike Monitors - Newser
What makes Dianthus Therapeutics Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
How Dianthus Therapeutics Inc. stock performs during market volatilityFree Stock Selection - Newser
Why Dianthus Therapeutics Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.9%Should You Sell? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 8.4%Should You Buy? - MarketBeat
DNTH’s Stock Market Adventure: -16.38% YTD Growth Amidst Volatility - investchronicle.com
What is William Blair's Estimate for DNTH FY2025 Earnings? - MarketBeat
William Blair Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
FY2025 Earnings Estimate for DNTH Issued By William Blair - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated at William Blair - Defense World
Dianthus Therapeutics stock rises after William Blair initiates coverage By Investing.com - Investing.com Canada
Dianthus Therapeutics Shares Climb After Analyst Coverage Boost - MSN
William Blair Initiates Dianthus Therapeutics at Outperform - MarketScreener
Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 6%Time to Sell? - MarketBeat
Is Dianthus Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Dianthus Therapeutics Inc (DNTH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):